相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The Novel Role of Tyrosine Kinase Inhibitor in the Reversal of Immune Suppression and Modulation of Tumor Microenvironment for Immune-Based Cancer Therapies
Junko Ozao-Choy et al.
CANCER RESEARCH (2009)
Activated CD4+ T Cells Dramatically Enhance Chemotherapeutic Tumor Responses In Vitro and In Vivo
Soroosh Radfar et al.
JOURNAL OF IMMUNOLOGY (2009)
Cancer statistics, 2008
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2008)
Combined modality immunotherapy and chemotherapy: a new perspective
Rupal Ramakrishnan et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2008)
Paradigm shifts in cancer vaccine therapy
Jeffrey Schlom et al.
EXPERIMENTAL BIOLOGY AND MEDICINE (2008)
Enhancing efficacy of therapeutic vaccinations by combination with other modalities
James L. Gulley et al.
VACCINE (2007)
Cancer vaccines: Moving beyond current paradigms
Jeffrey Schlom et al.
CLINICAL CANCER RESEARCH (2007)
Tremelimumab (CP-675,206), a cytotoxic T lymphocyte-associated antigen 4 blocking monoclonal antibody in clinical development for patients with cancer
Antoni Ribas et al.
ONCOLOGIST (2007)
Phase 1, pharmacokinetic (PK) and pharmacodynamic (PD) study of oral alvespimycin (A; KOS-1022; 17-DMAG): Two different schedules in patients with advanced malignancies
K. T. Flaherty et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Clinical activity and immune modulation in cancer patients treated with CP-870,893, a novel CD40 agonist monoclonal antibody
Robert H. Vonderheide et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
All-trans-retinoic acid improves differentiation of myeloid cells and immune response in cancer patients
Noweeda Mirza et al.
CANCER RESEARCH (2006)
A randomized phase II study of concurrent docetaxel plus vaccine versus vaccine alone in metastatic androgen-independent prostate cancer
PM Arlen et al.
CLINICAL CANCER RESEARCH (2006)
Combination of p53 cancer vaccine with chemotherapy in patients with extensive stage small cell lung cancer
SJ Antonia et al.
CLINICAL CANCER RESEARCH (2006)
Unexpected association between induction of immunity to the universal tumor antigen CYP1B1 and response to next therapy
JG Gribben et al.
CLINICAL CANCER RESEARCH (2005)
Treatment of recurrent small cell lung cancer
AM Davies et al.
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA (2004)
Clinical responsiveness of glioblastoma multiforme to chemotherapy after vaccination
CJ Wheeler et al.
CLINICAL CANCER RESEARCH (2004)
Mechanisms and functional significance of tumour-induced dendritic-cell defects
D Gabrilovich
NATURE REVIEWS IMMUNOLOGY (2004)
Topotecan in the treatment of recurrent small cell lung cancer: An update
A Ardizzoni
ONCOLOGIST (2004)
Silencing of death receptor and caspase-8 expression in small cell lung carcinoma cell lines and tumors by DNA methylation
S Hopkins-Donaldson et al.
CELL DEATH AND DIFFERENTIATION (2003)
Immature myeloid cells and cancer-associated immune suppression
S Kusmartsev et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2002)
An effective immunization and cancer treatment with activated dendritic cells transduced with full-length wild-type p53
EY Nikitina et al.
GENE THERAPY (2002)
Management of small cell lung cancer
BE Johnson
CLINICS IN CHEST MEDICINE (2002)
Mechanism of immune dysfunction in cancer mediated by immature Gr-1+ myeloid cells
DI Gabrilovich et al.
JOURNAL OF IMMUNOLOGY (2001)
Increased production of immature myeloid cells in cancer patients: A mechanism of immunosuppression in cancer
B Almand et al.
JOURNAL OF IMMUNOLOGY (2001)
分享论文
